ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 764 • 2013 ACR/ARHP Annual Meeting

    Inflammatory Disease Due To Dysregulated Nuclear Factor-κB Activation and Impaired Type I Interferon Response Resulting From a De Novo Human NEMO Hypomorphic Mutation

    Alex Wessel1, Amy Hsu2, Jevgenia Zilberman-Rudenko1, Raphaela Goldbach-Mansky3, Richard M. Siegel1 and Eric Hanson1, 1Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Laboratory of Clinical Infectious Diseases, NIAID, Bethesda, MD, 3Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD

    Background/Purpose: The NF-kB family of transcription factors regulate innate and adaptive immunity, in addition to driving pro-inflammatory-disease states.  The type I interferon response acts in…
  • Abstract Number: 765 • 2013 ACR/ARHP Annual Meeting

    Angiogenic Factor Dysregulation and Risk Of Adverse Pregnancy Outcome In Lupus Pregnancies

    Jane E. Salmon1, Mimi Kim2, Marta M. Guerra3, Michael D. Lockshin4, Ware D. Branch5, Michelle Petri6, Carl A. Laskin7, Joan T. Merrill8, Lisa R. Sammaritano1, Jill P. Buyon9 and S. Ananth Karumanchi10, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, 3Rheumatology 3rd Fl Rsrch, Hospital for Special Surgery, New York, NY, 4Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 5Obsterics and Gynecology, Univ of Utah, Salt Lake City, UT, 6Johns Hopkins University School of Medicine, Baltimore, MD, 7University of Toronto and LifeQuest Centre for Reproductive Medicine, Toronto, ON, Canada, 8Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 10Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: Pregnant women with lupus and APL are at increased risk for adverse outcomes, particularly preeclampsia (PE), yet identification of those destined for complications remains…
  • Abstract Number: 766 • 2013 ACR/ARHP Annual Meeting

    Cholesterol Accumulation By Synovial Lining Macrophages Results In Ectopic Bone Formation During Experimental Osteoarthritis

    Wouter de Munter1, Arjen B. Blom1, Monique M. Helsen1, Birgitte Walgreen1, Peter M. van Der Kraan1, Leo A. Joosten2, Wim B. van den Berg3 and Peter L. van Lent4, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Department of Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 3Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands, 4Rheumatology Research & Advanced Therpeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Synovial macrophages have previously shown to play a significant role in the etiopathology of experimental collagenase-induced osteoarthritis (OA). In addition to production of pro-inflammatory…
  • Abstract Number: 727 • 2013 ACR/ARHP Annual Meeting

    Adiponectin Promotes The Differentiation Of naïve T Cell To Th17 Cell and Aggravates Collagen-Induced Arthritis

    Miaojia Zhang1, Xiaoxuan Sun2, Wenfeng Tan3, Xiaoke Feng4 and Ke Gan5, 1Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, CHINA., Nanjing, China, 2Department of Rheumatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, CHINA, Nanjing, China, 3Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 4Rheumatology, the First Affiliated Hospital of Nanjing Medical University, China, Nanjing, China, 5Rheumatology Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China

    Background/Purpose: To investigate a role of Adiponectin (AD) on the differentiation of naïve T cell to Th17 cell and bone erosion in collagen-induced arthritis (CIA)…
  • Abstract Number: 728 • 2013 ACR/ARHP Annual Meeting

    Unraveling The Identity Of FoxP3+ Regulatory T-Cells In Gpa-Patients

    WH Abdulahad1, Coen A. Stegeman2, MG Huitema1, Pieter C. Limburg3, Abraham Rutgers1, Peter Heeringa4 and Cees G.M. Kallenberg1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Nephrology, University Medical Center Groningen, Groningen, Netherlands, 3Department of Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands, 4Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Human FoxP3+ Th-cells are heterogeneous in function and include not only suppressive cells (TRegs) but also non-suppressive cells that abundantly secrete proinflammatory cytokines. We…
  • Abstract Number: 729 • 2013 ACR/ARHP Annual Meeting

    Role Of Innate Immunity In The Pathogenesis Of ANCA-Associated Vasculitis

    Angelica Gattamelata1, Giovanna Peruzzi2, Rossana Scrivo3, Roberta Priori3, Stefania Morrone4, Angela Santoni2 and Guido Valesini3, 1Sapienza University of Rome, Rome, Italy, 2Department of Molecular Medicine, Sapienza University, Rome, Italy, 3Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy, 4Department of Experimental Medicine, Sapienza University, Rome, Italy

    Background/Purpose: Natural killer cells (NK) represent one of the main effectors of the innate immune response through the defense against viral infections and the production…
  • Abstract Number: 730 • 2013 ACR/ARHP Annual Meeting

    Cell-Mediated Immune Responses To Influenza and Herpesvirus Antigen Stimulation Are Conserved But Adversely Impacted By Immunosuppressive Therapy and Active Infection In Patients With Granulomatosis With Polyangiitis

    John McKinnon1, Robbie Mailliard2, Dawn McClemens-McBride3, Donald Jones3, Charles Rinaldo Jr.4 and Kathleen Maksimowicz-McKinnon5, 1Infectious Disease, Henry Ford Hospital, Detroit, MI, 2Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, 3Rheumatology, University of Pittsburgh, Pittsburgh, PA, 4Infectious Diseases and Microbiology, Pathology, University of Pittsburgh, Pittsburgh, PA, 5Rheumatology, Henry Ford Hospital, Detroit, MI

    Background/Purpose: Reactivation of chronic herpesvirus infections is not uncommon in immunosuppressed patients, including those with granulomatosis with polyangiitis (GPA).  The effects of GPA disease and…
  • Abstract Number: 731 • 2013 ACR/ARHP Annual Meeting

    C3 Activation Is Associated With The Disease Activity Of Microscopic Polyangiitis

    Dan Liu1,2,3, Jin-song Zhou4, Qing-ping Chen4, Chao-yang Duan1, Li Wang4, Yuan Jia3 and Ke Li1, 1Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China, 2Department of Rheumatology and Immunology, The Fifth Hospital of Xi'an, Xi'an, China, 3Department of Rheumatology and Immunology,Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 4Department of Rheumatology and Immunology, The Fifth Hospital of Xi'an, Xi’an, China

    Background/Purpose: Microscopic polyangiitis (MPA) is the most common anti-neutrophil cytoplasmic antibodies(ANCA) associated small-vessel vasculitis with specificity of the ANCA to myeloperoxidase(MPO) of neutrophils. MPA mainly…
  • Abstract Number: 732 • 2013 ACR/ARHP Annual Meeting

    Expansion Of IgA-Plasma Cells As a Sign For Ear-Nose-Throat-Involvment In Granulomatosis With Polyangiitis?

    Bimba F. Hoyer1,2, Adriano Taddeo3, Qingyu Cheng2, Laleh Khodadadi2, Gerd Burmester2 and Falk Hiepe2, 1Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, 2Charité University Medicine, Department of Medicine/Rheumatology and Clinical Immunology and German Rheumatism Research Centre Berlin (DRFZ), Germany, Berlin, Germany, 3Deutsches Rheumaforschungszentrum, Berlin, Germany

    Background/Purpose: B cells are playing a major role in granulomatosis with polyangiitis (GPA, formarly known as Wegener’s disease). This is reflected by the presence of…
  • Abstract Number: 733 • 2013 ACR/ARHP Annual Meeting

    Plasma Levels Of Fibrin/Fibrinogen Degradation Products Might Be a Useful Indicator Of Disease Activity, Classification and Nephritis Complications In Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

    Kuninobu Wakabayashi, Nao Oguro, Yoko Miura, Sho Ishii, Shinya Seki, Masayu Umemura, Takahiro Tokunaga, Hiroyuki Tsukamoto, Sakiko Isojima, Hidekazu Furuya, Ryo Yanai, Kumiko Otsuka, Ryo Takahashi, Takeo Isozaki, Nobuyuki Yajima, Yusuke Miwa and Tsuyoshi Kasama, Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan

    Background/Purpose: It is important to determine the biomarkers for assessing disease activity of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Plasma levels of fibrin/fibrinogen…
  • Abstract Number: 734 • 2013 ACR/ARHP Annual Meeting

    The Significance Of Anti-Myeloperoxidase and Anti-Proteinase 3 Antibodies In The Absence Of Anti-Neutrophil Cytoplasmic Antibody Immunofluorescence Positivity

    Deepak A. Rao1, Joseph F. Merola1, William R. O'Brien1, Kevin Wei1, Samuel U. Takvorian2, Paul F. Dellaripa3 and Peter H. Schur1, 1Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Identification of serum anti-neutrophil cytoplasmic antibodies (ANCA) for the detection of ANCA-associated vasculitis (AAV) is often performed by screening with indirect immunofluorescence (IF), followed…
  • Abstract Number: 735 • 2013 ACR/ARHP Annual Meeting

    Clinical Research Of Microscopic Polyangiitis Combined With Autoimmune Hemolytic Anemia

    Dan Liu1,2,3, Qing-ping Chen4, Hai-hong Yao5, Ru Li1, Yin Su1, Jie Zhang4, Yu Chen4, Ke Li3 and Yuan Jia1, 1Department of Rheumatology and Immunology,Clinical Immunology Center, Peking University People's Hospital, Beijing, China, 2Department of Rheumatology and Immunology, The Fifth Hospital of Xi'an, Xi'an, China, 3Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China, 4Department of Rheumatology and Immunology, The Fifth Hospital of Xi'an, Xi’an, China, 5Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China

    Background/Purpose: Autoimmune hemolytic anemia (AIHA) and Microscopic polyangiitis (MPA) are both rare autoimmune conditions. AIHA is caused by autoantibody-induced hemolysis (the premature destruction of circulating…
  • Abstract Number: 736 • 2013 ACR/ARHP Annual Meeting

    Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Associated With Systemic Sclerosis In Japan: A Review Of The Literature

    Natsumi Nagao1, Yuri Sadanaga1, Satoko Tashiro1, Rie Suematsu1, Syuichi Koarada1, Akihide Ohta2 and Yoshifumi Tada1, 1Rheumatology, Saga University, Saga, Japan, 2Nursing, Saga University, Saga, Japan

    Background/Purpose: Cases of Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) during the course of systemic sclerosis (SSc) have recently been reported. Japanese cases of AAV associated…
  • Abstract Number: 738 • 2013 ACR/ARHP Annual Meeting

    Pulmonary Fibrosis In ANCA-Associated Vasculitis

    Cloé Comarmond1, Bruno Crestani2, Abdellatif Tazi3, Baptiste Hervier4, Sylvain Adam-Marchand5, Hilario Nunes6, Fleur Cohen-Aubart7, Marie Wislez8, Jacques Cadranel8, Bruno Housset9, Célia Lloret-Linares10, Pascal Sève11, Christian Pagnoux12, Sébastien Abad13, Juliette Camuset14, Boris Bienvenu15, Michael Duruisseaux16, Eric Hachulla17, Jean-Benoît Arlet18, Mohamed Hamidou19, Alfred Mahr20, Anne-Laure Brun21, Philippe Grenier21, Patrice Cacoub22 and David Saadoun23, 1Internal Medicine and Clinical Imunology, Referal Center for Autoimmune diseases, Internal Medicine and Clinical Imunology, Hôpital Pitié Salpétrière, Paris, France, 2Pneumology A, Hôpital Bichat, Paris, France, 3Hôpital Saint-Louis, Paris, France, 4Internal Medicine & Clinical Immunology Dpt, Pitié-Salpêtrière Hospital, APHP, Paris, France, 5Pneumology, Centre Hospitalier Universitaire de Tours, Tours, France, 6Department of Pneumology, Avicenne Hospital (AP-HP), Bobigny, France, 7Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, 8Pneumology, Hôpital Tenon, Paris, France, 9Pneumology, Centre Hospitalier Intercommunal de Créteil, Créteil, France, 10Médecine Interne A, Hôpital Lariboisière, Paris, France, 11Internal medicine, CHU Lyon, Lyon, France, 12Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, 13Internal Medicine, Avicenne Hospital, Bobigny, France, 14Pneumology, Centre Hospitalier Victor Dupouy, Argenteuil, France, 15Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, 16Pneumology, CHU de Grenoble, Grenoble, France, 17Internal Medicine, Lille CEDEX, France, 18Internal Medicine, HEGP, Paris, France, 19Internal Medicine Department, Nantes University Hospital, Nantes, France, 20Department of Internal Medicine, Hospital Saint-Louis, Paris, France, 21Radiology, Hôpital Pitié-Salpêtrière, Paris, France, 22Médecine Interne 2, Hopital Pitié-Salpétrière, Paris, France, 23Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France

    Background/Purpose: The association of pulmonary fibrosis (PF) with anti neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), especially microscopic polyangiitis (MPA), is rare but related to poor…
  • Abstract Number: 739 • 2013 ACR/ARHP Annual Meeting

    Cardiac Involvement In Granulomatosis With Polyangiitis

    Lucy McGeoch1, Simon Carette2, David Cuthberston3, Gary S. Hoffman4, Nader A. Khalidi5, Curry L Koening6, Carol A. Langford7, Paul A. Monach8, Larry W. Moreland9, Philip Seo10, Ulrich Specks11, Steven R. Ytterberg12, Carol McAlear13, Peter A Merkel14, Christian Pagnoux2 and The Vcrc15, 1Vasculitis clinic, Division of rheumatology, Mount Sinai Hospital, University Health Network, University of Toronto, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 3Biostatistics, University of South Florida, Tampa, FL, 4Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 5Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, 6Division of rheumatology, George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, University of Utah School of Medicine, Salt Lake City, UT, 7Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 8Rheumatology, Boston University, Boston, MA, 9Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 10Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, 11Mayo Clinic, Rochester, MN, 12Rheumatology Division, Mayo Clinic, Rochester, MN, 13University of Pennsylvania, Philadelphia, PA, 14Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 15University of Pennsylvania and VA Medical Center, Philadelphia, PA

    Background/Purpose: Prior cohort studies in Europe have found cardiac involvement to be rare in granulomatosis with polyangiitis (GPA) but associated with significant increases in mortality…
  • « Previous Page
  • 1
  • …
  • 2198
  • 2199
  • 2200
  • 2201
  • 2202
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology